Author: Nicholas Alan Clayton

4dpharma

Longevity Acquisition Corporation (LOAC) Shareholders Approve 4D pharma Deal

Longevity Acquisition Corporation (NASDAQ:LOAC) announced that its shareholders unanimously approved its combination with biotechnology firm 4D pharma plc (AIM:DDDD) at a special meeting held March 17. The combined entity is expected to have its first American Depositary Shares trading on the Nasdaq beginning Monday, March 22. In a separate move, 4D also announced a $24
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
IPO-Pricing
IPO-Pricing
forum-iv-logo
IPO-Pricing
IPO-Pricing
IPO-Pricing
Nuvve-logo

Newborn Acquisition Corp. (NBAC) Shareholders Approve Nuvve Deal

Newborn (NASDAQ:NBAC) announced that its shareholders have approved its combination with EV technology firm Nuvve at a special meeting held last evening. The parties now expect the deal to be completed in the next few days, after which the combined company’s shares and warrants will trade on the Nasdaq under the symbols “NVVE” and “NVVEW”,
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
IPO-Pricing
IPO-Pricing
IPO-Pricing
purecycle-tech.2

FinTech Acquisition Corp. V (FTCV) to Combine with eToro in $9.6Bn Deal

FinTech V (NASDAQ:FTCV) has entered into a definitive agreement to combine with eToro at an enterprise value of $9.595 billion, or 9.7x its 2022E revenue. eToro is an online multi-asset investment platform with features like social investing and proprietary “smart portfolios.” The parties expect to complete the deal in the third quarter of 2021. Transaction
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
IPO-Pricing
IPO-Pricing
IPO-Pricing